Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer

被引:26
|
作者
Heindl, Andreas [1 ,2 ,3 ]
Lan, Chunyan [4 ,5 ]
Rodrigues, Daniel Nava [6 ]
Koelble, Konrad [3 ,7 ]
Yuan, Yinyin [1 ,2 ,3 ]
机构
[1] Inst Canc Res, Ctr Evolut & Canc, London, England
[2] Royal Marsden Hosp, Ctr Mol Pathol, London, England
[3] Inst Canc Res, Div Mol Pathol, London, England
[4] Sun Yat Sen Univ, Dept Gynecol Oncol, Ctr Canc, Guangzhou, Guangdong, Peoples R China
[5] Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Guangdong, Peoples R China
[6] Inst Canc Res, Div Canc Therapeut, London, England
[7] Royal Marsden Hosp, Dept Histopathol, London, England
基金
英国惠康基金;
关键词
high-grade serous ovarian cancer; locally advanced disease; tumor microenvironment; automated image analysis; ecological diversity; INTRAEPITHELIAL CARCINOMA; OPPORTUNITIES; PERSPECTIVES; BEVACIZUMAB; THERAPIES; INSIGHTS; ECOLOGY; SURGERY; WOMEN;
D O I
10.18632/oncotarget.12106
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment is pivotal in influencing cancer progression and metastasis. Different cells co-exist with high spatial diversity within a patient, yet their combinatorial effects are poorly understood. We investigate the similarity of the tumor microenvironment of 192 local metastatic lesions in 61 ovarian cancer patients. An ecologically inspired measure of microenvironmental diversity derived from multiple metastasis sites is correlated with clinicopathological characteristics and prognostic outcome. We demonstrate a high accuracy of our automated analysis across multiple sites. A low level of similarity in microenvironmental composition is observed between ovary tumor and corresponding local metastases (stromal ratio r = 0.30, lymphocyte ratio r = 0.37). We identify a new measure of microenvironmental diversity derived from Shannon entropy that is highly predictive of poor overall (p = 0.002, HR = 3.18, 95% CI = 1.51-6.68) and progression- free survival (p = 0.0036, HR = 2.83, 95% CI = 1.41-5.7), independent of and stronger than clinical variables, subtype stratifications based on single cell types alone and number of sites. Although stromal influence in ovary tumors is known to have significant clinical implications, our findings reveal an even stronger impact orchestrated by diverse cell types. Quantitative histology-based measures can further enable objective selection of patients who are in urgent need of new therapeutic strategies such as combinatorial treatments targeting heterogeneous tumor microenvironment.
引用
收藏
页码:71123 / 71135
页数:13
相关论文
共 50 条
  • [2] A Complex Network of Tumor Microenvironment in Human High-Grade Serous Ovarian Cancer
    Kreuzinger, Caroline
    Geroldinger, Angelika
    Smeets, Dominiek
    Braicu, Elena Ioana
    Sehouli, Jalid
    Koller, Julia
    Wolf, Andrea
    Darb-Esfahani, Silvia
    Joehrens, Korinna
    Vergote, Ignace
    Vanderstichele, Adriaan
    Boeckx, Bram
    Lambrechts, Diether
    Gabra, Hani
    Wisman, G. Bea A.
    Trillsch, Fabian
    Heinze, Georg
    Horvat, Reinhard
    Polterauer, Stephan
    Berns, Els
    Theillet, Charles
    Castillo-Tong, Dan Cacsire
    CLINICAL CANCER RESEARCH, 2017, 23 (24) : 7621 - 7632
  • [3] The Tumor Microenvironment of High Grade Serous Ovarian Cancer
    Stack, M. Sharon
    Nephew, Kenneth P.
    Burdette, Joanna E.
    Mitra, Anirban K.
    CANCERS, 2019, 11 (01):
  • [4] LAMOTRIGINE MONOTHERAPY ASSOCIATES WITH IMPROVED PROGRESSION-FREE AND OVERALL SURVIVAL IN HIGH-GRADE GLIOMA
    Rilinger, Ryan
    Sharma, Akshay
    Feldman, Marina
    Guo, Lydia
    Volovetz, Josephine
    Grabowski, Matthew
    Lobbous, Mina
    NEURO-ONCOLOGY, 2024, 26
  • [5] Properties of the immune microenvironment associated with clonal diversity in high-grade serous ovarian cancer
    Zhang, Allen W.
    McPherson, Andrew
    Roth, Andrew
    Kroeger, David R.
    Milne, Katy
    Wasserman, Wyeth W.
    McAlpine, Jessica N.
    Holt, Robert A.
    Nelson, Brad H.
    Shah, Sohrab P.
    CANCER RESEARCH, 2016, 76
  • [6] The peritoneal tumour microenvironment of high-grade serous ovarian cancer
    Leinster, D. Andrew
    Kulbe, Hagen
    Everitt, Gemma
    Thompson, Richard
    Perretti, Mauro
    Gavins, Felicity N. E.
    Cooper, Dianne
    Gould, David
    Ennis, Darren P.
    Lockley, Michelle
    McNeish, Iain A.
    Nourshargh, Sussan
    Balkwill, Frances R.
    JOURNAL OF PATHOLOGY, 2012, 227 (02): : 136 - 145
  • [7] Prognostic features of the tumor microenvironment in high-grade serous ovarian cancer and dietary immunomodulation
    Mckenzie, Nathalie D.
    Ahmad, Sarfraz
    Awada, Ahmad
    Kuhn, Theresa M.
    Recio, Fernando O.
    Holloway, Robert W.
    LIFE SCIENCES, 2023, 333
  • [8] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    van Baal, J. O. A. M.
    Lok, C. A. R.
    Jordanova, E. S.
    Horlings, H.
    van Driel, W. J.
    Amant, F. C.
    Van de Vijver, K. K.
    VIRCHOWS ARCHIV, 2020, 477 (04) : 535 - 544
  • [9] The effect of the peritoneal tumor microenvironment on invasion of peritoneal metastases of high-grade serous ovarian cancer and the impact of NEOADJUVANT chemotherapy
    J. O. A. M. van Baal
    C. A. R. Lok
    E. S. Jordanova
    H. Horlings
    W. J. van Driel
    F. C. Amant
    K. K. Van de Vijver
    Virchows Archiv, 2020, 477 : 535 - 544
  • [10] Low MAD2 expression levels associate with reduced progression-free survival in patients with high-grade serous epithelial ovarian cancer
    Furlong, Fiona
    Fitzpatrick, Patricia
    O'Toole, Sharon
    Phelan, Sine
    McGrogan, Barbara
    Maguire, Aoife
    O'Grady, Anthony
    Gallagher, Michael
    Prencipe, Maria
    McGoldrick, Aloysius
    McGettigan, Paul
    Brennan, Donal
    Sheils, Orla
    Martin, Cara
    Kay, Elaine W.
    O'Leary, John
    McCann, Amanda
    JOURNAL OF PATHOLOGY, 2012, 226 (05): : 746 - 755